BID and glioblastoma: Taken together, these results indicate that enhancing signal inputs into the Caspase-8/Caspase-3/Bid triad would be expected to modestly increase cell death; whereas MOMP sensitization would be expected to potentiate cell death in otherwise TRAIL/TL32711-resistant GBM cell lines.